Secondary prophylaxis for variceal bleeding: carvedilol vs. propranolol

Steib, Christian; Gerbes, Alexander L.

doi:10.1007/s12072-017-9791-4

Cited by 2 publications

(2 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[7] Recently, the use of carvedilol has been showed to be superior to the old beta blocker, propranolol. [8] It is also can be used to delay the variceal growth. In fact, the use of carvedilol has been showed to be superior also to EBL procedure for re-bleeding prevention.…”

Section: Strategy Management In Acute Variceal Bleeding Preventionmentioning

confidence: 99%

Esophageal Varices Rebleeding Prophylaxis Treatment: Who Is the Champion?

Lesmana

2024

InaJGHE

View full text Add to dashboard Cite

Portal hypertension (PH) is still a big challenge in clinical practice, where the presence of esophageal varices (EV) is the most common complication found in liver cirrhosis (LC) patients. The progression of PH condition in LC patients would lead to decompensated stage with more complications, such as variceal bleeding, the presence of ascites, hepatic encephalopathy, and hepatorenal syndrome.[1,2] Bleeding of EV (BEV) is a critical clinical which carry high mortality. Therefore, not only early detection and how the PH condition can be diagnosed well, but also how we can manage to prevent its complication, especially for primary as well as secondary BEV prophylaxis.[3]

show abstract

Section: Strategy Management In Acute Variceal Bleeding Preventionmentioning

confidence: 99%